The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
CAMPASS: Benmelstobart in combination with anlotinib vs pembrolizumab in the first-line treatment of advanced non-small cell lung cancer (aNSCLC)—A randomized, single-blind, multicenter phase 3 study.
 
Baohui Han
No Relationships to Disclose
 
Kai Li
No Relationships to Disclose
 
Runxiang Yang
No Relationships to Disclose
 
Yongzhong Luo
No Relationships to Disclose
 
Wei Zuo
No Relationships to Disclose
 
Chao Xie
No Relationships to Disclose
 
Qingshan Li
No Relationships to Disclose
 
Xingxiang Xu
No Relationships to Disclose
 
Qiang Liu
No Relationships to Disclose
 
Yan Yu
No Relationships to Disclose
 
Qiming Wang
No Relationships to Disclose
 
Tienan Yi
No Relationships to Disclose
 
Yongxing Chen
No Relationships to Disclose
 
Hongmei Sun
No Relationships to Disclose
 
Xuhong Min
No Relationships to Disclose
 
Huaqiu Shi
No Relationships to Disclose
 
Hualin Chen
No Relationships to Disclose
 
Jianhua Shi
No Relationships to Disclose
 
Jinsheng Shi
No Relationships to Disclose
 
Junzhen Gao
No Relationships to Disclose